| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119111 | Journal of Autoimmunity | 2016 | 9 Pages |
Abstract
Using primary cells isolated from 3 murine and 6 human individuals, this preclinical study demonstrated similar therapeutic effects using allogeneic or xenogeneic BM-MSC while ASC exerted potent anti-inflammatory and remodeling properties. This sets the proof-of-concept prompting to evaluate the therapeutic efficacy of allogeneic ASC in SSc patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alexandre T.J. Maria, Karine Toupet, Marie Maumus, Guillaume Fonteneau, Alain Le Quellec, Christian Jorgensen, Philippe Guilpain, Danièle Noël,